文献速递脑血管病

脑白质疏松与急性卒中溶栓后脑出血及功能结局

Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis.
PubMed 文献 · Neurology · 2017-01-27

该系统综述与汇总荟萃分析纳入15项研究共6967例接受静脉或动脉溶栓的急性缺血性卒中患者,评估治疗前神经影像上的脑白质疏松与症状性颅内出血(sICH)及3个月不良功能结局(改良Rankin量表[mRS]≥2)的关联。结果显示,任何程度脑白质疏松及中重度脑白质疏松均与sICH风险升高和功能结局不良相关,各分析未见统计学异质性。

要点

  • 治疗前影像存在脑白质疏松者溶栓后sICH风险升高(RR 1.65)。
  • 中重度脑白质疏松者sICH风险进一步升高(RR 2.4)。
  • 脑白质疏松亦与3个月不良功能结局相关(RR 1.30)。

核心结论

  • 脑白质疏松的存在与严重程度与急性缺血性卒中静脉或动脉溶栓后sICH风险升高及功能结局不良持续相关。

研究设计与样本

  • 纳入15项研究、共6967例接受静脉或动脉溶栓的急性缺血性卒中患者。
  • 评估治疗前CT或MRI所示脑白质疏松与3个月mRS或sICH的关系。
  • 采用随机效应模型计算汇总相对危险度(RR)。

主要发现

  • 任何脑白质疏松 vs 无:sICH的RR为1.65(n=5551;95%CI 1.26-2.16,p=0.001),绝对风险增加2.5%。
  • 中重度 vs 无至轻度脑白质疏松:sICH的RR为2.4(n=4192;95%CI 1.83-3.14,p=0.001),绝对风险增加6.2%。
  • 任何脑白质疏松 vs 无:不良功能结局的RR为1.30(n=3401;95%CI 1.19-1.42,p=0.001),绝对风险增加15.4%。
  • 中重度 vs 无至轻度脑白质疏松:不良功能结局的RR为1.31(n=3659;95%CI 1.22-1.42,p=0.001),绝对风险增加17.5%。
  • 各分析均未见统计学异质性。

关键数值与推荐

  • sICH评估:任何脑白质疏松RR 1.65(95%CI 1.26-2.16,p=0.001),中重度RR 2.4(95%CI 1.83-3.14,p=0.001)。
  • 不良功能结局(mRS≥2)评估:任何脑白质疏松RR 1.30(95%CI 1.19-1.42,p=0.001),中重度RR 1.31(95%CI 1.22-1.42,p=0.001)。
  • 脑白质疏松分级采用任意评定量表,或Van Swieten、Fazekas Schmidt量表区分无至轻度与中重度。

临床怎么用

  • 对拟行静脉或动脉溶栓的急性缺血性卒中患者,治疗前应评估脑白质疏松的存在与严重程度以辅助风险分层。
  • 中重度脑白质疏松者溶栓后sICH绝对风险增加更明显,知情沟通与监测可据此加强。

局限性

  • 纳入研究为已发表研究的汇总分析,原始研究的设计差异与患者选择偏倚可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a systematic review and pooled meta-analysis of published studies to assess whether the presence of leukoaraiosis on neuroimaging before treatment with thrombolysis (IV or intra-arterial) is associated with an increased risk of symptomatic intracerebral hemorrhage (sICH) or poor functional outcome. METHODS: We included studies of patients with acute ischemic stroke, treated with IV or intra-arterial thrombolysis, which assessed functional outcome (3-month modified Rankin Scale [mRS]) or sICH in relation to leukoaraiosis on pretreatment neuroimaging (CT or MRI). We used random-effects models to calculate pooled relative risks (RR) of sICH and poor functional outcome (mRS ≥ 2) for any vs no leukoaraiosis (using any rating scale) and for no to mild vs moderate to severe leukoaraiosis (using the Van Swieten or Fazekas Schmidt scale). RESULTS: We identified 15 studies (total n = 6,967). For sICH outcome, the RR was 1.65 (n = 5,551; 95% confidence interval [CI] 1.26-2.16, p = 0.001) with an absolute risk (AR) increase of 2.5% for any leukoaraiosis vs none. The RR was 2.4 (n = 4,192; 95% CI 1.83-3.14, p = 0.001) with an AR increase of 6.2% for moderate to severe vs no to mild leukoaraiosis. For poor functional outcome; the RR was 1.30 (n = 3,401; 95% CI 1.19-1.42, p = 0.001) with an AR increase of 15.4% for any leukoaraiosis vs none. The RR was 1.31 (n = 3,659; 95% CI 1.22-1.42, p = 0.001) with an AR increase of 17.5% for moderate to severe vs no to mild leukoaraiosis. No statistical heterogeneity was noted for any of the analyses. CONCLUSIONS: Leukoaraiosis presence and severity are consistently associated with an increased risk of sICH and poor functional outcome after IV or intra-arterial thrombolysis for acute ischemic stroke.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kongbunkiat K, Wilson D, Kasemsap N, et al. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis. Neurology. 2017. PMID: 28130468. doi:10.1212/WNL.0000000000003605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。